Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies

ClinicalTrials.gov ID: NCT02048917

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02048917. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 5:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to find an optimal smoking cessation strategy in patients undergoing therapy for lung and head and neck cancers at selected cancer centers in Kentucky by delivering high quality smoking cessation to all enrolled patients. This study will also examine the feasibility of routinely implementing an array of smoking cessation strategies for this patient population.

Study identification

NCT ID: NCT02048917
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: University of Kentucky; Other
Enrollment: 93 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 22, 2014 (Actual)
Primary completion: May 15, 2019 (Actual)
Completion: May 15, 2019 (Actual)
Last update posted: Jan 29, 2020

2014 – 2019

United States locations

U.S. sites: 10
U.S. states: 2
U.S. cities: 8

Facility	City	State	ZIP	Site status
King's Daughters Medical Center	Ashland	Kentucky	41101	—
Hardin Memorial Health Cancer Care Center	Elizabethtown	Kentucky	42701	—
ARH Cancer Center	Hazard	Kentucky	41701	—
Kentucky Cancer Clinic	Hazard	Kentucky	41701	—
Lexington Veterans Affair Medical Center	Lexington	Kentucky	40502	—
University Of Kentucky, Markey Cancer Center	Lexington	Kentucky	40536	—
University of Louisville, James Graham Brown Cancer Center	Louisville	Kentucky	40202	—
St. Claire Regional Medical Center	Morehead	Kentucky	40351	—
Owensboro Health	Owensboro	Kentucky	42303	—
St. Mary's Medical Center	Huntington	West Virginia	25702	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02048917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 29, 2020 · Synced Nov 14, 2026